Prasoon Singh Patel
Data Analyst@ KMK Consulting | EX- Genpact |Machine Learning |Deep Learning | NLP | Generative AI | SQL | Python | PySpark | Excel | Power BI | APLD | KOMODO | DATABRICKS | Healthcare Analytics
- Role
- Associate at KMK Consulting Inc.
- Location
- Lakhimpur, UP, IN
- LinkedIn followers
- 500 followers
About Prasoon Singh Patel
I am skilled in SQL, Python, PySpark, Excel, and Power BI. I navigate complex data…
Experience
Associate
Dec 2024 — Present
Project: Patient Journey Analysis for Bladder Cancer – (Phase 3 Drug)ObjectiveSupported in developing and positioning its Phase 3 bladder cancer drug by conducting a comprehensive patient journey analysis, with a focus on BCG-unresponsive patients, the key target group for the trial.Key Activities & Deliverables1.Cohort Creation: Built a bladder cancer patient cohort from real-world data with clear inclusion/exclusion criteria.2.Risk Stratification: Applied AUA guidelines to classify patients into low-risk (LR) and high-risk (HR) groups.3.Treatment Flow Mapping: Created treatment flow diagrams for LR and HR patients, showing therapy progression.4.BCG-Unresponsive Identification: Segmented and quantified patients unresponsive to BCG; mapped therapies like cystectomy, immunotherapies, and off-label treatments.5.Comorbidity Profiling: Assessed cardiovascular, renal, and metabolic conditions influencing treatment choices.6.HCP & HCO Journey: Tracked patient pathways across specialists and identified top HCOs with high BC volumes.7.Side Effect Analysis: Compared safety profiles of therapies to highlight tolerability gaps.Why We Did It1.To clarify treatment patterns and unmet needs in bladder cancer.2.To profile the BCG-unresponsive subgroup critical for clinical trial success.3.To provide real-world insights for trial design, HCP targeting, and future market access.Outcomes1.Delivered a 360° framework of the bladder cancer journey with LR, HR, and BCG-unresponsive flows.2.Quantified market opportunity for BCG-unresponsive patients.3.Highlighted comorbidities and side effects shaping treatment decisions.4.Identified key specialties and HCOs to support trial site selection and commercialization.5.Equipped the Client with evidence-based insights to differentiate its Phase 3 therapy and strengthen positioning in a competitive market.Tools Used:SQL, Python, Excel, PowerPoint
Education
Banaras Hindu University
M.Sc.
2020 — 2022
University of Lucknow
B.sc
2017 — 2020
Find verified contacts for anyone on LinkedIn
Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.
Free plan included · No credit card required
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.